Search

Displaying results 1011 - 1020 of 10000 in total
  1. Drug

    4-[211At]-L-phenylalanine

    go.drugbank.com/drugs/DB18164
    Experimental

    Synonyms: 4-[211At]-L-phenylalanine
  2. Drug

    4-Bromo-2,5-dimethoxyphenethylamine

    go.drugbank.com/drugs/DB01537
    IllicitInvestigational

    Categories: Adrenergic alpha-1 Receptor AgonistsSynonyms: 2C-B
  3. Drug

    2s,4r-4-Methylglutamate

    go.drugbank.com/drugs/DB03425
    Experimental

    Synonyms: 2s,4r-4-Methylglutamate
  4. Drug

    S-(4-nitrobenzyl)glutathione

    go.drugbank.com/drugs/DB03686
    Experimental

    Synonyms: S-(4-nitrobenzyl)glutathione, S-(p-nitrobenzyl)glutathione
  5. Drug

    4-hydroxybutan-2-one

    go.drugbank.com/drugs/DB04094
    Experimental

    Synonyms: 4-Hydroxy-2-butanone, 4-hydroxybutan-2-one
  6. Drug

    2-Amino-4-methylphenol

    go.drugbank.com/drugs/DB04533
    Experimental

    Synonyms: 2-Amino-4-methylphenol, 4-Methyl-2-aminophenol
  7. Drug

    3-thiaoctanoyl-CoA

    go.drugbank.com/drugs/DB03415
    Experimental

    Synonyms: 3-thiaoctanoyl-coenzyme A, 3-thiaoctanoyl-CoA
  8. Drug

    TN-201

    go.drugbank.com/drugs/DB18700
    Investigational

    TN-201 is a gene therapy comprising a native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type human MYBPC3 gene.

    Synonyms: Native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type human MYBPC3 gene
  9. Drug

    Osimertinib

    go.drugbank.com/drugs/DB09330
    ApprovedInvestigational

    testing and which has progressed following therapy with a first-generation EGFR tyrosine kinase inhibitor. … Approximately 10% of patients with NSCLC have a rapid and clinically effective response to EGFR-TKIs due to the presence of specific activating EGFR mutations within the tumour cells.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic IndexSynonyms: N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide
  10. Drug

    Mesalazine

    go.drugbank.com/drugs/DB00244
    ApprovedInvestigational

    Although demonstrably effective in treating and maintaining remission for ulcerative colitis, mesalazine has historically faced a number of issues regarding its lack of stability as a pharmaceutical agent … An anti-inflammatory agent, structurally related to the salicylates and non-steroidal anti-inflammatory drugs like acetylsalicylic acid, which is active in inflammatory bowel disease [A174022].

    Synonyms: m-Aminosalicylic acid, 3-carboxy-4-hydroxyanilineProducts: MESALAZINA EG, MESALAZINA EG STADA